Managing suspected meningococcal disease: a case-based clinical approach

Invasive meningococcal disease (IMD), caused by Neisseria meningitidis , is a life-threatening infection that requires rapid recognition and immediate antimicrobial treatment. This case examines the assessment, diagnosis and management of suspected IMD in a 23-year-old male, with a particular focus on evidence-based prescribing and the role of the non-medical prescriber (NMP). A structured assessment was undertaken using the Calgary–Cambridge model, integrating both subjective and objective data, including clinical findings, laboratory investigations and timely pharmacological intervention. The patient presented with fever, a purpuric rash, photophobia and headache, features consistent with suspected IMD. The patient was treated with intravenous ceftriaxone 2 g 12-hourly and oral ibuprofen 400 mg 8-hourly. Serogroup C IMD was subsequently confirmed in hospital, and the patient made a full recovery within 10 days without adverse effects. This case highlights the importance of early clinical recognition and the prompt administration of third-generation cephalosporins in improving outcomes. It reinforces the need for adherence to evidence-based guidelines and underscores the pivotal role of NMPs in delivering safe, timely, and effective care in acute, high-risk presentations.